Nevertheless, GLP-1 presented a rather ephemeral circulatory half-life, lasting a mere 12 min, due to the rapid enzymatic degradation by dipeptidyl peptidase IV (DPP-4), which markedly limits its biological efficacy [3,4,5]
Switching from tirzepatide A growing number of researchers are transitioning from tirzepatide to retatrutide, typically because they have hit a tirzepatide weight loss plateau or want to push past the weight loss ceiling of dual agonism
Eli Lilly sues companies selling alternative versions of its weight loss drug Eli Lilly, the drugmaker behind the blockbuster weight loss drug Zepbound, is suing four telehealth companies for allegedly selling illegal copies of the drug made by compounding pharmacies
"I think we should all celebrate and really be delighted by the fact that there are more tools in the toolbox to help people trying to manage their weight." Jennifer VanGilder, a 51-year-old economics professor at Ursinus College in Collegeville, Pennsylvania, said she'd tried countless methods to lose weight, from strict diets to services like the defunct Jenny Craig